Indeed, co-transfer of WT host-type spleen DCs (which contain CD8α+ DCs) and T cells into allogeneic B2m−/− recipients, which are functionally deficient in antigen presentation, induced a significant CD8+ T cell-mediated GVL response, leading to prolonged survival of recipients without tumor. The gene discussed is CD8A; the disease is neoplasm.